19 articles for D Kumar
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis, evaluation and molecular modelling studies of 2-(carbazol-3-yl)-2-oxoacetamide analogues as a new class of potential pancreatic lipase inhibitors.
Birla Institute of Technology
Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes.
S.E.T'S College of Pharmacy
Sequential one-pot synthesis of bis(indolyl)glyoxylamides: Evaluation of antibacterial and anticancer activities.
Birla Institute of Technology
Microwave assisted synthesis of naphthopyrans catalysed by silica supported fluoroboric acid as a new class of non purine xanthine oxidase inhibitors.
Guru Nanak Dev University
Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.
National Institute of Diabetes and Digestive and Kidney Diseases
Click chemistry inspired one-pot synthesis of 1,4-disubstituted 1,2,3-triazoles and their Src kinase inhibitory activity.
Institute of Technology and Science
Recent advancements in the development of heterocyclic anti-inflammatory agents.
Isf College of Pharmacy
Paradigm shift of "classical" HDAC inhibitors to "hybrid" HDAC inhibitors in therapeutic interventions.
National Institute of Pharmaceutical Education and Research (NIPER)
Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Indian Institute of Technology (Banaras Hindu University)
Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors.
Biota Holdings
Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease.
Banaras Hindu University
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.
Banaras Hindu University
Design and synthesis of bis(indolyl)ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors.
Birla Institute of Technology
Compound having KDM5 inhibitory activity and pharmaceutical use thereof
Ono Pharmaceutical
Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
Ocuterra Therapeutics